On Tuesday, Immatics N.V (NASDAQ: IMTX) opened higher 3.83% from the last session, before settling in for the closing price of $4.18. Price fluctuations for IMTX have ranged from $4.18 to $13.77 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 90.52% over the past five years. Company’s average yearly earnings per share was noted 48.49% at the time writing. With a float of $87.13 million, this company’s outstanding shares have now reached $103.11 million.
Let’s look at the performance matrix of the company that is accounted for 343 employees. In terms of profitability, gross margin is 43.41%, operating margin of -58.2%, and the pretax margin is -41.57%.
Immatics N.V (IMTX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Immatics N.V is 27.00%, while institutional ownership is 75.18%.
Immatics N.V (IMTX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 48.49% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.70% during the next five years compared to -17.16% drop over the previous five years of trading.
Immatics N.V (NASDAQ: IMTX) Trading Performance Indicators
Check out the current performance indicators for Immatics N.V (IMTX). In the past quarter, the stock posted a quick ratio of 3.98. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.65, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.17 in one year’s time.
Technical Analysis of Immatics N.V (IMTX)
Immatics N.V (NASDAQ: IMTX) saw its 5-day average volume 0.57 million, a negative change from its year-to-date volume of 1.1 million. As of the previous 9 days, the stock’s Stochastic %D was 23.24%. Additionally, its Average True Range was 0.28.
During the past 100 days, Immatics N.V’s (IMTX) raw stochastic average was set at 3.92%, which indicates a significant decrease from 23.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.81% in the past 14 days, which was lower than the 50.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.70, while its 200-day Moving Average is $9.51. Nevertheless, the first resistance level for the watch stands at $4.46 in the near term. At $4.59, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.79. If the price goes on to break the first support level at $4.14, it is likely to go to the next support level at $3.94. The third support level lies at $3.81 if the price breaches the second support level.
Immatics N.V (NASDAQ: IMTX) Key Stats
There are currently 119,356K shares outstanding in the company with a market cap of 518.00 million. Presently, the company’s annual sales total 58,440 K according to its annual income of -104,980 K. Last quarter, the company’s sales amounted to 55,590 K and its income totaled -9,420 K.
